JP2004500553A5 - - Google Patents

Download PDF

Info

Publication number
JP2004500553A5
JP2004500553A5 JP2001528702A JP2001528702A JP2004500553A5 JP 2004500553 A5 JP2004500553 A5 JP 2004500553A5 JP 2001528702 A JP2001528702 A JP 2001528702A JP 2001528702 A JP2001528702 A JP 2001528702A JP 2004500553 A5 JP2004500553 A5 JP 2004500553A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001528702A
Other versions
JP2004500553A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2000/027682 external-priority patent/WO2001025791A2/en
Publication of JP2004500553A publication Critical patent/JP2004500553A/ja
Publication of JP2004500553A5 publication Critical patent/JP2004500553A5/ja
Pending legal-status Critical Current

Links

JP2001528702A 1999-10-07 2000-10-06 前立腺ガンのマーカータンパク質 Pending JP2004500553A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15842299P 1999-10-07 1999-10-07
PCT/US2000/027682 WO2001025791A2 (en) 1999-10-07 2000-10-06 Prostate cancer marker proteins

Publications (2)

Publication Number Publication Date
JP2004500553A JP2004500553A (ja) 2004-01-08
JP2004500553A5 true JP2004500553A5 (ja) 2005-12-15

Family

ID=22568045

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001528702A Pending JP2004500553A (ja) 1999-10-07 2000-10-06 前立腺ガンのマーカータンパク質

Country Status (7)

Country Link
EP (1) EP1224466B1 (ja)
JP (1) JP2004500553A (ja)
AT (1) ATE350662T1 (ja)
AU (1) AU7868300A (ja)
CA (1) CA2386669A1 (ja)
DE (1) DE60032784T2 (ja)
WO (1) WO2001025791A2 (ja)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE356357T1 (de) * 2000-03-20 2007-03-15 Eastern Virginia Med School Prostatakrebs-marker
AUPQ886100A0 (en) * 2000-07-19 2000-08-10 Biotron Limited Diagnostic test
GB2379737A (en) * 2001-09-05 2003-03-19 Univ Geneve Diagnostic method for spongiform encephalopathy disease
EP1485461A4 (en) * 2002-02-21 2005-06-22 Eastern Virginia Med School PROTEIN BIOMARKERS DISTINGUISHING PROSTATE CANCER OF NON-MALIGNIC CELLS
EP1556702A2 (en) 2002-10-30 2005-07-27 Proteome Sciences Plc Diagnostic methods for transmissible spongiform encephalopathies (prion diseases)
WO2004059320A1 (ja) 2002-12-26 2004-07-15 Nitto Boseki Co., Ltd. 免疫測定法およびそれに用いるキット
WO2004090550A2 (en) 2003-04-08 2004-10-21 Colotech A/S A method for detection of colorectal cancer in human samples
US7425700B2 (en) 2003-05-22 2008-09-16 Stults John T Systems and methods for discovery and analysis of markers
JP4568551B2 (ja) * 2004-07-28 2010-10-27 一晃 掛樋 糖たん白質糖鎖の分析方法及び非標識糖鎖の製造方法
US20090298184A1 (en) 2005-04-07 2009-12-03 Harald Mischak Polypeptide Markers for the Diagnosis of Prostate Cancer
CA2644330C (en) 2006-03-24 2012-05-01 Phenomenome Discoveries Inc. Biomarkers useful for diagnosing prostate cancer, and methods thereof
GB0617429D0 (en) 2006-09-05 2006-10-18 Electrophoretics Ltd Markers of renal transplant rejection and renal damage
EP2012127A3 (en) * 2007-07-03 2009-03-11 Koninklijke Philips Electronics N.V. Diagnostic markers for detecting prostate cancer
US20140134658A1 (en) * 2010-05-21 2014-05-15 Notrhwestern University, An Illinois Not For Profit Corporation Psa enzymatic activity: a new biomarker for assessing prostate cancer aggressiveness
JP2013528379A (ja) * 2010-05-21 2013-07-11 オームクス コーポレーション Ｐｓａ酵素活性アッセイによる癌の検出
CA2835806A1 (en) 2011-05-13 2012-11-22 King's College London Methods and compositions relating to platelet sensitivity
WO2015042493A2 (en) * 2013-09-20 2015-03-26 Ohmx Corporation Psa enzymatic activity: a new biomarker for assessing prostate cancer aggressiveness
IL303893A (en) 2019-08-05 2023-08-01 Seer Inc Systems and methods for sample preparation, data generation and corona protein analysis

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6143864A (en) * 1994-06-28 2000-11-07 Merck & Co., Inc. Peptides
US5866679A (en) * 1994-06-28 1999-02-02 Merck & Co., Inc. Peptides
US5807978A (en) * 1995-06-07 1998-09-15 Kokolus; William J. Immunogenic peptides of prostate specific antigen
JP2001518085A (ja) * 1997-03-11 2001-10-09 スローン ケタリング インスティテュート フォー キャンサー リサーチ 前立腺特異的抗原基質
US6207370B1 (en) * 1997-09-02 2001-03-27 Sequenom, Inc. Diagnostics based on mass spectrometric detection of translated target polypeptides
US6300088B1 (en) * 1997-11-24 2001-10-09 Duke University Method of detecting prostate specific antigen
WO1999037811A1 (en) * 1998-01-21 1999-07-29 Urocor, Inc. Biomarkers and targets for diagnosis, prognosis and management of prostate disease
WO1999061471A2 (en) * 1998-05-29 1999-12-02 Incyte Pharmaceuticals, Inc. Human transmembrane proteins

Similar Documents

Publication Publication Date Title
BE2015C062I2 (ja)
BE2013C060I2 (ja)
BE2011C041I2 (ja)
BE2011C032I2 (ja)
BE2010C009I2 (ja)
BE2009C057I2 (ja)
JP2003513917A5 (ja)
JP2002535695A5 (ja)
JP2001283071A5 (ja)
JP2001032620A5 (ja)
JP2004500553A5 (ja)
JP2001232882A5 (ja)
JP2003504119A5 (ja)
IN2002CH01751A (ja)
JP2003503854A5 (ja)
JP2002181562A5 (ja)
CN300955183S (zh) 连接件
CN3152302S (ja)
CN3143841S (ja)
CN3141752S (ja)
CN3141567S (ja)
CN3141409S (ja)
CN3141400S (ja)
CN3141398S (ja)
CN3142225S (ja)